<code id='4105B7BA79'></code><style id='4105B7BA79'></style>
    • <acronym id='4105B7BA79'></acronym>
      <center id='4105B7BA79'><center id='4105B7BA79'><tfoot id='4105B7BA79'></tfoot></center><abbr id='4105B7BA79'><dir id='4105B7BA79'><tfoot id='4105B7BA79'></tfoot><noframes id='4105B7BA79'>

    • <optgroup id='4105B7BA79'><strike id='4105B7BA79'><sup id='4105B7BA79'></sup></strike><code id='4105B7BA79'></code></optgroup>
        1. <b id='4105B7BA79'><label id='4105B7BA79'><select id='4105B7BA79'><dt id='4105B7BA79'><span id='4105B7BA79'></span></dt></select></label></b><u id='4105B7BA79'></u>
          <i id='4105B7BA79'><strike id='4105B7BA79'><tt id='4105B7BA79'><pre id='4105B7BA79'></pre></tt></strike></i>

          entertainment

          entertainment

          author:focus    Page View:77927
          Lee Klafczynski for STAT

          WASHINGTON — Congress is considering a must-pass pandemic preparedness bill that presents a good opportunity to fix the nation’s current drug shortages problem, which both parties want to do. But most indications are that lawmakers will let that opportunity pass them by.

          Although not new, drug shortages are now a crisis, with an increasing number of reports about cancer doctors having to ration chemotherapies and other drugs.

          advertisement

          Politicians have been well aware of the problem for years. At the request of a large bipartisan group of lawmakers, a task force chaired by the Food and Drug Administration in 2019 reported on the root causes of drug shortages.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          leisure time

          Activists slam private health insurers over coverage restrictions
          Activists slam private health insurers over coverage restrictions

          ProtestorsoutsideAmerica'sHealthInsurancePlansheadquarters.CourtesyPeople'sActionWASHINGTON—Hun

          read more
          Changes to biosimilar regulatory framework must prioritize patients
          Changes to biosimilar regulatory framework must prioritize patients

          JUANMABROMATA/AFPviaGettyImagesBiosimilarsarenolongeranewanduntestedclassofmedicines.Today,theyprovi

          read more
          Peter Hotez and the public health issue of online harassment
          Peter Hotez and the public health issue of online harassment

          AdobeFather’sDayweekendwasanythingbutcalmonTwitter,whicheruptedasvaccineexpertPeterHotezwaschallenge

          read more

          Medical bills so high, Medicare adding extra digits to claim forms

          AlexHogan/STATWASHINGTON—Healthcarecostsaregettingsohighthatpricesareliterallyrunningoffofthepage.Me